RJA
MBII

Raymond James & Associates’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Raymond James & Associates’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-48,489
Closed -$59K – 3922
2020
Q3 		$59K Hold
48,489
– – ﹤0.01% 3435
2020
Q2 		$57K Sell
48,489
-1,812
-4% -$1.68K ﹤0.01% 3365
2020
Q1 		$41K Sell
50,301
-2,760
-5% -$2.93K ﹤0.01% 3341
2019
Q4 		$54K Buy
53,061
+2,277
+4% +$2.76K ﹤0.01% 3544
2019
Q3 		$72K Sell
50,784
-3,065
-6% -$4.33K ﹤0.01% 3435
2019
Q2 		$81K Buy
53,849
+26,957
+100% +$41.7K ﹤0.01% 3438
2019
Q1 		$41K Buy
+26,892
New +$41K ﹤0.01% 3489

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Raymond James & Associates's MBII Position: Q4 2020 in Review

Raymond James & Associates sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2020, closing a stake of 48,489 shares — an estimated $59K sold.

Raymond James & Associates first reported a position in MBII in Q1 2019 and held it in 7 quarters. The position peaked at $81K in Q2 2019. 62 funds tracked by Wall St. Rank hold MBII as of Q4 2020.

  • Raymond James & Associates reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2020 after selling out during the quarter.
  • Raymond James & Associates sold 48,489 Marrone Bio Innovations, Inc. shares in Q4 2020, an estimated $59K.
  • Raymond James & Associates first reported a position in Marrone Bio Innovations, Inc. in Q1 2019 and held it in 7 quarters.
  • Raymond James & Associates's Marrone Bio Innovations, Inc. position peaked at $81K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.